IBD is a spectrum of chronic disorders that constitute an important health problem worldwide. The hunt for genetic determinants of disease onset and course has culminated in the Immunochip project, which has identified >160 loci containing IBD susceptibility genes. In this Review, we highlight how genetic association studies have informed our understanding of the pathogenesis of IBD by focusing research efforts on key pathways involved in innate immunity, autophagy, lymphocyte differentiation and chemotaxis. Several of these novel genetic markers and cellular pathways are promising candidates for patient stratification and therapeutic targeting. © 2014 Macmillan Publishers Limited.
CITATION STYLE
Van Limbergen, J., Radford-Smith, G., & Satsangi, J. (2014). Advances in IBD genetics. Nature Reviews Gastroenterology and Hepatology. Nature Publishing Group. https://doi.org/10.1038/nrgastro.2014.27
Mendeley helps you to discover research relevant for your work.